Siemens gets FDA nod for Intevo SPECT/CT
Article Thumbnail ImageSeptember 5, 2013 -- Siemens Healthcare has garnered U.S. Food and Drug Administration 510(k) clearance for its Symbia Intevo SPECT/CT system.

To get access to this article and all of the content on, create a free account or sign-in now.

Member Sign In:
  MemberID or E-mail Address:

New Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • Intevo, the first member of Siemens' xSPECT product family, integrates data from both SPECT and CT modalities and generates high-resolution as well as quantitative SPECT images, according to the vendor.

    Siemens has also included its CARE Dose4D technique, which can reduce patient CT radiation dose by up to 68%, while the system's Autoform collimator captures up to 26% more photon counts from radiotracer activity, according to the vendor.

    Siemens first unveiled Intevo at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in June.

    || About || Advertising || || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 All Rights Reserved.